Cytosine Arabinoside-Induced PC12 Cell Death Pathway

Cytosine Arabinoside 유도된 PC12 세포의 사망 경로

  • Yang, Bo-Gee (Department of Biochemistry and Molecular Biology, College of Science, Hanyang University) ;
  • Yang, Byung-Hwan (Department of Neuropsychiatry, College of Medicine, Hanyang University) ;
  • Chai, Young-Gyu (Department of Biochemistry and Molecular Biology, College of Science, Hanyang University)
  • 양보기 (한양대학교 이과대학 생화학 및 분자생물학과) ;
  • 양병환 (한양대학교 의과대학 신경정신과학교실) ;
  • 채영규 (한양대학교 이과대학 생화학 및 분자생물학과)
  • Published : 1998.12.25

Abstract

Cytosine arabinoside(AraC) inhibits DNA synthesis and ${\beta}$-DNA polymerase, an enzyme involved in DNA repair. This, a potent antimitotic agent, is clinically used as an anticancer drug with side effect of severe neurotoxicity. Earlier reports suggested that inhibition of neuronal survival by AraC in sympathetic neuron may be due to the inhibition of a 2'-deoxycytidine-dependent process that is independent of DNA synthesis or repair and AraC induced a signal that is triggers a cascade of new mRNA and protein synthesis, leading to apoptotic cell death in cultured cerebellar granule cells. The present study would suggest whether caspase family(ICE/CED-3-like protease) involved in AraC-induced apoptosis pathway of PC12 cells. It was observed that treatment of PC12 cells with AraC led to decrease of viability by MTT assay and morphology changes, which did not suggest that AraC induced apoptosis in PC12 cells. The mRNA of caspase-1/caspase-3 were expressed in PC12 cells constitutively, and AraC did not activate caspase family. These results suggest that caspase-1/caspase-3 may not be required for AraC-induced cell death pathway in PC12 cells.

Keywords

Acknowledgement

Supported by : 한양대학교